Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01732965 · ClinicalTrials.gov registry record · Phase 4

NB-UVB and PUVA Vitiligo Study

A Phase 4 study, sponsored by Henry Ford Health System.

Completed
Registry status
Phase 4
Development phase
10
Enrollment target

NCT01732965: Completed Phase 4 study, sponsored by Henry Ford Health System.

NCT01732965 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01732965, a Phase 4 study, has completed, sponsored by Henry Ford Health System.

COMPLETED
Registry status
Phase 4
Development phase
10 participants
Enrollment target

Study Summary

To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.

Primary Outcome

Determination the degree of repigmentation measured by the VASI score (Vitiligo area Scoring Index) after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.

Interventions

  • OTHER Phototherapy
  • OTHER Phototherapy and Photochemotherapy

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2013-03
Est. Completion 2014-05
Phase Phase 4
Henry Ford Health System

234 total trials

What the finished NCT01732965 record still lists

NCT01732965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Phototherapy is the first listed.

NCT01732965 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01732965 about?

NCT01732965 is a clinical study titled "NB-UVB and PUVA Vitiligo Study". To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B is more effective than narrowband ultraviolet B alone in the treatment of vitiligo.

What is the current status of trial NCT01732965?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2013-03. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01732965?

The interventions under investigation include: Phototherapy (OTHER), Phototherapy and Photochemotherapy (OTHER).

Who is sponsoring clinical trial NCT01732965?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01732965's enrollment target sits among peer trials

10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01732965, the US trial registry maintained by the National Library of Medicine. NCT01732965 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.